Recro Pharma, Inc. (NASDAQ:REPH) is currently trading at $2.57 up 1.58% in the Pre-market. Will REPH move upward or will move in the narrow range like last trading session?
REPH lost 3.44% in last session and closed the day at $2.53 on a volume of 0.165 million shares. It has a market cap of $78.430 million, while its average volume is 0.485 million.
REPH Signs Agreement
RecroPharma, Inc. intends to use the net proceed from this offering for general corporate purposes.
- REPH A contract development and manufacturing challenges for companies developing oral solid dose drug products announced that it is signing a development agreement with Astex Pharmaceuticals, Inc. a leading developer of novel therapeutics for cancer.
- RecroPharma announced on May 14, 2021, the closing of its previously announced underwritten public offerings of 15 million shares including 1.99 million shares sold to under the underwriters.
- REPH’s approximate gross proceeds to Recropharma from this offering is $34.5 million before underwriters discount and commission and estimated offering expenses.
|SHARES OUTSTANDING||31.03 M|
|SHARE FLOAT (%)||26.88 M (86.64%)|
|% HELD BY INSTITUTIONS||63.04|
Recent Stock Performance
|+/- EMA(20)||2.68 (-5.60%)|
|+/- SMA(50)||3.02 (-16.23%)|
|+/- SMA(200)||2.86 (-11.54%)|
|CCI20||-61.5589||Sell||Chaikin Money Flow||0.1036||Buy|
|MACD||-0.2069||Sell||Money Flow Index||31.6485||Sell|
|STOCH (14,3)||32.6087||Sell||STOCH RSI||0.5158||Neutral|